Institute For Neurodegenerative Disorders Revenue, Growth & Competitor Profile

DBA I N D
DBA INSTITUTE FOR NEURODEGENERATIVE DISORDER

Company Profile & Annual Report for Institute For Neurodegenerative Disorders

Access the complete profile.

Institute For Neurodegenerative Disorders Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	54172 Research & Development in the Social Sciences & Humanities
Address	60 Temple Street Suite 8b New Haven, CT 06510

Note: Revenues for privately held companies are statistical evaluations.


Institute For Neurodegenerative Disorders's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Institute For Neurodegenerative Disorders's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Institute For Neurodegenerative Disorders is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Institute For Neurodegenerative Disorders Annual Revenue and Growth Rate

Institute For Neurodegenerative Disorders	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Institute For Neurodegenerative Disorders's revenues are gauged from an analysis of company filings.

Institute For Neurodegenerative Disorders's Income Statement (based on Industry Averages)

Institute For Neurodegenerative Disorders P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Institute For Neurodegenerative Disorders's Largest Competitors

A competitive analysis shows these companies are in the same general field as Institute For Neurodegenerative Disorders, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Institute For Neurodegenerative Disorders. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOHAVEN PHARMACEUTICALS	New Haven, CT	100
ARVINAS	New Haven, CT	42
INVICRO	New Haven, CT	8
ACHILLION PHARMACEUTICALS	New Haven, CT	4
INSTITUTE FOR NEURODEGENERATIVE DISORDERS	New Haven, CT	3
ATLASXOMICS	New Haven, CT	2

Other Companies at 60 Temple Street, New Haven CT

Company	Headquarters	Revenue ($ MM)
INVICRO	New Haven, CT	100
NEW HAVEN RHEUMATOLOGY PC	New Haven, CT	15
ROSLYN P. EINBINDER M.D.	New Haven, CT	1
COMPLETE FOOTCARE	New Haven, CT	1
PULMONARY ASSOCIATES OF NEW HAVEN P.C.	New Haven, CT	0

Future Competition: Institute For Neurodegenerative Disorders's Fastest Growing Competitors

These companies are in the same general field as Institute For Neurodegenerative Disorders and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)